跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 99 条关于
“macrocyclic GBCAs”
全部
99
临床试验
20
药物
21
机构
0
资讯
58
去年
Bayer's Gadoquatrane Achieves Positive Phase III Results with Reduced Gadolinium Dose
9个月前
Bayer's Low-Dose MRI Contrast Agent Gadoquatrane Shows Promise in Pediatric Study
去年
Bayer to Showcase Advanced Radiology Portfolio and Novel Contrast Agent at ECR 2025
9个月前
FDA Expands Max 3™ Syringeless MRI Injector for Use with VUEWAY® Imaging Bulk Package
9个月前
EMA Committee Recommends Vueway for Pediatric Patients Under 2 Years, Addressing Critical Unmet Need in Neonatal Imaging
3个月前
Bayer's AMBELVIST® (gadoquatrane) Receives FDA Approval as Lowest-Dose Macrocyclic Gadolinium-Based Contrast Agent for MRI
9个月前
Syneron Bio Secures Nearly $100M Series A Funding for Macrocyclic Peptide Platform
去年
Argenx Partners with Unnatural Products in $1.5 Billion Macrocyclic Peptide Deal
7个月前
Unnatural Products Partners with Novartis in $1.7 Billion Macrocyclic Peptide Deal for Cardiovascular Therapeutics
5个月前
Syneron Bio Secures $150M Series B to Advance Macrocyclic Peptide Drug Discovery Platform
第 1 页,共 6 页
上一页
下一页